Evidence map›Paper›PMID 41482590›Full record

ArticleNature neuroscience2026

TGFβ signaling mediates microglial resilience to spatiotemporally restricted myelin degeneration.

Keying Zhu, Yun Liu, Jin-Hong Min, Vijay Joshua, Jianing Lin, Yue Li, Judith C Kreutzmann, Yuxi Guo, Wenlong Xia, Elyas Mohammadi and 13 more

Erratum issuedAbstract read
In one paragraph

Article in Nature neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Keying ZhuApplied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-7500-1532
Yun LiuState Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Sciences, Institutes of Brain Science, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0001-5753-1265
Jin-Hong MinApplied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Vijay JoshuaDivision of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-2606-8180
Jianing LinApplied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Yue LiDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-0584-1119
Judith C KreutzmannDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Yuxi GuoApplied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Wenlong XiaDepartment of Neurology, Division of Neuroimmunology and Glial Biology, University of California San Francisco, San Francisco, CA, USA.
Elyas MohammadiDivision of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Melanie PieberApplied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Valerie SuerthApplied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Yiming XiaApplied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Zaneta AndrusivovaScience for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
Jean-Philippe HugnotInstitut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.
Shigeaki KanataniDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-2226-4288
Per UhlénDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-1446-1062
Joakim LundebergScience for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-4313-1601
Xiaofei LiDivision of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-9991-7534
Stephen P J FancyDepartment of Neurology, Division of Neuroimmunology and Glial Biology, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-2818-8258
Heela SarlusApplied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-7880-9828
Robert A Harris *Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden. robert.harris@ki.se.ORCID http://orcid.org/0000-0003-4990-509X
Harald Lund *Department of Physiology and Pharmacology, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden. harald.lund@ki.se.ORCID http://orcid.org/0000-0001-8046-0805

Funding

Regulation of Cellular Pathwaysin Human Brain DevelopmentP01NS083513 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALVAREZ-BUYLLA, ARTURO · 2014 to 2024
$12.6M
Mechanisms of oligodendroglial ciliary function in white matter injury repairR01NS128021 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Stephen Philip James Fancy · 2023 to 2026
$1.6M
Astrocytes control the termination of oligodendrocyte precursor cell perivascular migration during CNS developmentR21NS133891 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FANCY, STEPHEN PHILIP JAMES · 2023 to 2023
$444k
Neuroförbundet (Swedish Association of Persons with Neurological Disabilities) F2023-0059NINDS NIH HHS P01 NS083513NINDS NIH HHS R01 NS128021NINDS NIH HHS R21 NS133891Svenska Sällskapet för Medicinsk Forskning (Swedish Society for Medical Research) PD21-0017U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS128021U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R21NS133891Vetenskapsrådet (Swedish Research Council) 2021-01926Vetenskapsrådet (Swedish Research Council) 2023-06516Vetenskapsrådet (Swedish Research Council) 2024-02509
6 · The paper itself

Abstract

Microglia survey and regulate central nervous system myelination during embryonic development and adult homeostasis. However, whether microglia-myelin interactions are spatiotemporally regulated remains unexplored. Here, by examining spinal cord white matter tracts in mice, we determined that myelin degeneration was particularly prominent in the dorsal column (DC) during normal aging. This was accompanied by molecular and functional changes in DC microglia as well as an upregulation of transforming growth factor beta (TGF)β signaling. Disrupting TGFβ signaling in microglia led to unrestrained microglial responses and myelin loss in the DC, accompanied by neurological deficits exacerbated with aging. Single-nucleus RNA-sequencing analyses revealed the emergence of a TGFβ signaling-sensitive microglial subset and a disease-associated oligodendrocyte subset, both of which were spatially restricted to the DC. We further discovered that microglia rely on a TGFβ autocrine mechanism to prevent damage of myelin in the DC. These findings demonstrate that TGFβ signaling is crucial for maintaining microglial resilience to myelin degeneration in the DC during aging. This highlights a previously unresolved checkpoint mechanism of TGFβ signaling with regional specificity and spatially restricted microglia-oligodendrocyte interactions.

Indexed as

MicrogliaMyelin SheathSignal TransductionTransforming Growth Factor betaAgingAnimalsMaleMiceMice, Inbred C57BLOligodendrogliaSpinal CordWhite MatterTransforming Growth Factor beta

Identifiers

PMID41482590
PMCPMC12971496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.